US FDA qualifies first AI tool to help speed liver disease drug development

0
88
The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the agency said on Monday.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here